0001209191-19-021625.txt : 20190328 0001209191-19-021625.hdr.sgml : 20190328 20190328162128 ACCESSION NUMBER: 0001209191-19-021625 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190327 FILED AS OF DATE: 20190328 DATE AS OF CHANGE: 20190328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Rachel K. CENTRAL INDEX KEY: 0001589712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 19712254 MAIL ADDRESS: STREET 1: C/O GLYCOMIMETICS, INC. STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-27 0 0001000694 NOVAVAX INC NVAX 0001589712 King Rachel K. C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 0 0 0 Common Stock 2019-03-27 4 P 0 42000 0.5298 A 42000 D Common Stock 2019-03-27 4 P 0 22000 0.5298 A 22000 I See Footnote Common Stock 2019-03-27 4 P 0 22000 0.5298 A 22000 I See Footnote Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child. Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child. /s/ John A. Herrmann III, Attorney-in-Fact 2019-03-28